BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Jeena Sikho Lifecare Ltd. Share Price

NSE
BSE

NSE : JSLL

BSE : 544476

Sector : Trading

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹641.10

High

₹749.65

Price Summary

Previous Close ₹651.90
Day's Range ₹641.10 - ₹749.65
Open ₹697.95
52 Week Range ₹400.25 - ₹849.50
Volume 2,34,46,938
Market Cap ₹0.01

Stocks Summary

Trade Value ( ₹ in Lacs) 1,62,509.94
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.69
Price/Earning (TTM) 36.64
TTM EPS (₹) 17.85
P/E Ratio 1.32
Book Value(₹) 17.40
PAT Margin (%) 16.37
Face Value (₹) 2.00
ROCE(%) 53.05

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 4690.72 1392.51
Expenses N/A N/A
PBT 1075.77 339.15
Operating profit 0.0 0.0
Net profit 799.43 253.4

Shareholding Pattern

Promoters (% Holding)

63.62%

Mutual funds (% Holding)

0.11%

Non-Institution (% Holding)

29.76%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

6.17%

About Jeena Sikho Lifecare Ltd.

Founded 2017
Managing Director Manish Grover
NSE Symbol JSLL

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Adani Enterprises Ltd. 3,86,967.43 2,972.80 1,753.00 - 1,753.00
Premier Energies Ltd. 48,958.67 1,077.00 660.00 - 660.00
Aditya Infotech Ltd. 41,640.11 3,533.30 0.00 - 0.00
Aegis Logistics Ltd. 26,546.13 756.30 576.10 - 576.10
Redington Ltd. 19,313.74 247.05 191.31 - 191.31
Honasa Consumer Ltd. 13,559.79 416.90 248.40 - 248.40
Lloyds Enterprises Ltd. 10,247.74 67.13 40.69 - 40.69
MMTC Ltd. 10,231.50 68.21 50.10 - 50.10
Cello World Ltd. 8,520.64 386.80 365.00 - 365.00
Jeena Sikho Lifecare Ltd. 8,128.02 653.90 400.25 - 400.25
no-content No Records Found

Latest News

Mar
23
2026
EQUITY Posted on Mar 23rd 2026

Jeena Sikho Lifecare informs about publication of case study and case reports

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jeena Sikho Lifecare has informed that following academic publications, namely case studies and case reports, have been published in the International Journal of Advanced Research (IJAR). These publications have been authored by medical professionals associated with Jeena Sikho Lifecare, including Managing Director, senior consultants, and Ayurvedic experts. These publications demonstrate the Company’s ongoing commitment to Ayurvedic research and evidence-based clinical practice. The details of the case study and case reports are enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
Mar
9
2026
EQUITY Posted on Mar 9th 2026

Jeena Sikho Lifecare informs about board meeting proceedings

Jeena Sikho Lifecare has informed that the Board of Directors of the Company, at its meeting held today, March 09, 2026, has approved amendments to the ‘Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and Immediate Relatives of Designated Persons, and Legitimate Purpose Policy’ (Code). The amended Code and the intimation shall be made available on the website of the Company at https://jeenasikho.com/investors/.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
4
2026
EQUITY Posted on Jun 4th 2026

Cello World informs about record date for final dividend

Pursuant to Section 91 and other applicable provisions, if any of the Companies Act 2013 and Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Cello World has informed that the Record date has been fixed as on Friday, July 31, 2026 for determining entitlement of Members to final dividend for the financial year ended March 31, 2026, if approved at the Annual General Meeting, would be paid subject to deduction of tax at source, as may be applicable, on or after August 12, 2026, to those persons or their mandates whose names appear as Beneficial Owners as at the end of the business hours on Friday, July 31, 2026 (Record date) in the list of Beneficial Owners to be furnished by National Securities Depository Limited and Central Depository Services (India) in respect of the shares held.
The above information is a part of company’s filings submitted to BSE.  
Read More
Jun
4
2026
EQUITY Posted on Jun 4th 2026

Khazanchi Jewellers informs about investor presentation

Khazanchi Jewellers has enclosed the Investor/ Analysts presentation on the audited financial Results of Khazanchi Jewellers for the half year and year ended March 31, 2026. This presentation is being submitted in compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. The same is also being made available on the Company’s website www.khazanchi.co.in. 
The above information is a part of company’s filings submitted to BSE.  
Read More
Jun
4
2026
EQUITY Posted on Jun 4th 2026

Symphony informs about updates

Symphony has informed that the transfer has been completed through execution of the relevant agreements. An aggregate consideration of AUD 7.6 million (~₹52 crore) was remitted to CTPL in the current week, as under: AUD 4.3 million (~₹30 crore) towards transfer of 100% stake in BUSA; and AUD 3.3 million (~₹22 crore) towards transfer of the IPRs. As previously disclosed, CTPL has utilized the entire proceeds towards prepayment of working capital borrowings, reducing the outstanding borrowings to ~AUD 5.5 million (~₹37 crore). As conveyed earlier, henceforth the Company does not envisage any incremental capital allocation to its Australian subsidiaries as directed by the Board of Directors in its meeting held on May 15, 2026. Any future funding, if at all required, will be restricted to regulatory requirements, if any. This disclosure is being made pursuant to Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Jeena Sikho Lifecare Ltd. ?

The current share price of Jeena Sikho Lifecare Ltd. is ₹651.90 as of 2026-06-04.

The market capitalisation of Jeena Sikho Lifecare Ltd. is ₹8,128.02 as of 2026-06-04.

The 1-year return of Jeena Sikho Lifecare Ltd. is 0.00% as of 2026-06-04.

The P/E ratio of Jeena Sikho Lifecare Ltd. is 11.96 as of 2026-06-05.

The 52-week high and low of Jeena Sikho Lifecare Ltd. are ₹849.50 and ₹400.25, respectively, as of 2026-06-04.

The dividend yield of Jeena Sikho Lifecare Ltd. is 0.6882% as of2026-06-04.

You can buy Jeena Sikho Lifecare Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Jeena Sikho Lifecare Ltd. is Manish Grover.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

People Also Ask

Who is the owner of Jeena Sikho Lifecare Limited?

Jeena Sikho Lifecare Limited was founded by Manish Grover, who also functions as the Managing Director and is closely associated with the group’s strategic and operational decisions.

Jeena Sikho Lifecare Limited operates in the healthcare sector, offering Ayurvedic medicines, wellness products, Panchakarma therapies, clinics, and healthcare services through its Shuddhi brand and associated facilities.

The company focuses on integrated Ayurvedic healthcare by combining product manufacturing, clinical services, wellness programs, and therapy‑based treatments under a single operational healthcare model.

Jeena Sikho Lifecare provides access to traditional Ayurvedic treatments, preventive healthcare programs, and wellness therapies, which are structured around holistic health practices rather than symptom‑only treatment approaches.

Jeena Sikho Lifecare Limited is headquartered in Zirakpur, Punjab, and operates several clinics, wellness centres, and healthcare facilities across multiple locations in India.

Jeena Sikho Lifecare primarily competes with other Ayurvedic and wellness healthcare companies such as Charak, Ayushakti Ayurveda, and similar traditional healthcare service providers.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore